Welcome to ECVERY
4-chloro-6,7-di(2-methoxyethoxy)quinazoline
4-chloro-6,7-di(2-methoxyethoxy)quinazoline
Supplier Info
[China Supplier]
Contact Person : Ms. Yan Li
Tel : 86-512-88169812
Fax : 86-512-88169811
Product Detail
Erlotinib is an EGFR inhibitor. The drug follows Iressa gefitinib, which was the first drug of this type.

Erlotinib is an EGFR inhibitor. The drug follows Iressa gefitinib, which was the first drug of this type. Erlotinib specifically targets the epidermal growth factor receptor (EGFR) tyrosine kinase, which is highly expressed and occasionally mutated in various forms of cancer. It binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two members of the EGFR family need to come together to form a homodimer. These then use the molecule of ATP to autophosphorylate each other, which causes a conformational change in their intracellular structure, exposing a further binding site for binding proteins that cause a signal cascade to the nucleus. By inhibiting the ATP, autophosphorylation is not possible and the signal is stopped.

4-chloro-6,7-di(2-methoxyethoxy)quinazoline

Related Products
Ads by Google

About Us | Contact Us | Help | Terms & Conditions
Hot Products: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9
Copyright Notice @ 2008-2022 ECVERY Limited and/or its subsidiaries and licensors. All rights reserved.